Bharat Seats Approves FY26 Results, ₹86.61 Cr Capex, and Recommends 75% Dividend
Bharat Seats approved FY26 audited financial results and recommended a 75% dividend (₹1.50 per share). The company approved a capex of ₹86.61 crore for new Maruti Suzuki programs. The 39th AGM is scheduled for July 24, 2026. Mr. Rishabh Relan's re-appointment as Whole-time Director for three years was recommended.
The announcement includes crucial financial outcomes (annual results), a substantial dividend payout, a significant capital expenditure for future growth, and a key management re-appointment, all of which are material to investors.
The approval of financial results, recommendation of a significant dividend, significant capital expenditure for growth, and re-appointment of a key director contribute to a positive sentiment.
Bharat Seats Limited's Board of Directors, in a meeting held on May 6, 2026, approved the annual financial statements and audited financial results for the financial year ended March 31, 2026. The company also took note of the unmodified audit report from M/s S.R. Batliboi & Co., LLP.
Key financial decisions included the approval of a capital expenditure of approximately ₹86.61 crore for new Maruti Suzuki India Limited programs at its Kharkhoda and Gujarat Navyani plants. The Board recommended a dividend of 75%, equivalent to ₹1.50 per equity share of ₹2 each, for the financial year ended March 31, 2026. The record date for this dividend is set as July 17, 2026, and the dividend, subject to shareholder approval, will be paid within 30 days of declaration.
Furthermore, the Board approved the draft notice for the 39th Annual General Meeting (AGM), scheduled for Friday, July 24, 2026. They also approved the draft Directors' Report, Management Discussion and Analysis, and Corporate Governance Report for the year ended March 31, 2026. The revised CSR Policy was also approved.
In a significant human resources decision, the Board recommended the re-appointment of Mr. Rishabh Relan as Whole-time Director for another three-year term, from February 4, 2027, to February 3, 2030, subject to shareholder approval. Mr. Relan, son of Chairman & Managing Director Mr. Rohit Relan, has been with the company since August 2012 and has extensive experience in the automobile industry.
What to do with a filing like this
Bharat Seats Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Bharat Seats Limited. Read the original for the full detail.